Global Prenatal and New-born Genetic Testing Market Size, Status and Forecast 2020-2026

Market Analysis and Insights: Global Prenatal and New-born Genetic Testing Market
The global Prenatal and New-born Genetic Testing market size is projected to reach US$ 3920 million by 2026, from US$ 3647.2 million in 2020, at a CAGR of 6.9%% during 2021-2026.

Global Prenatal and New-born Genetic Testing Scope and Market Size
Prenatal and New-born Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prenatal and New-born Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
Perkin Elmer
Verinata Health
Sequenom, Inc.

Market segment by Type, the product can be split into

PCR
FISH
aCGH
NIPT
MSS

Market segment by Application, split into

Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India

Frequently Asked Questions